Mipro Pharmaceuticals Private Limited
About Mipro Pharmaceuticals Private Limited
Data last updated:
Mipro Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 11 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2010PTC211320. Its GSTIN is 10AAGCM9335B1ZX (Bihar).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Rajeev Ranjan and Dineshchandra Prasad Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 264 Ff Amar Colony, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.62 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹96,537 (net margin -6.2%) and EBITDA of -₹96,537 (EBITDA margin -6.2%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mipro Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 264 Ff Amar Colony, New Delhi, Delhi, India – 110024
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Mipro Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mipro Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mipro Pharmaceuticals Private Limited, buy the company report.
Financials of Mipro Pharmaceuticals Private Limited
FY 2025 filings availableMipro Pharmaceuticals Private Limited reported revenue of ₹15.62 Lakh (up 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA fell 508% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹96,537 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹96,537 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.2% | ||||
| Net Profit Margin | -6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mipro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mipro Pharmaceuticals Private Limited
Mipro Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Ranjan | Director | 04 Mar 2013 | 13 Years 7 Months | Current |
| Dineshchandra Prasad Gupta | Director | 04 Mar 2013 | 13 Years 7 Months | Current |
Peer comparison
Mipro Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Means Pharmaceuticals Private Limited | ₹15.82 Lakh (FY 2025) | 56.0% | Delhi, India | |||
| Yskp Pharmaceuticals Private Limited | ₹15.65 Lakh (FY 2025) | -3.0% | Thane, Maharashtra, India | |||
| Rolex Pharmaceuticals Limited | ₹15.63 Lakh (FY 2022) | 180.0% | Vadodara, Gujarat, India | |||
| Mipro Pharmaceuticals Private Limitedthis company | ₹15.62 Lakh (FY 2024) | -₹96,537 | -6.2% | 16.0% | 2 | New Delhi, Delhi, India |
| Narzi Pharmaceuticals Private Limited | ₹15.51 Lakh (FY 2022) | 1634.0% | Nalbari, Assam, India | |||
| Diar Pharmaceuticals Private Limited | ₹15.46 Lakh (FY 2022) | -19.0% | New Delhi, Delhi, India |
To see the full peer comparison of Mipro Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Mipro Pharmaceuticals Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Mipro Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mipro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mipro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mipro Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Mipro Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCM9335B1ZX | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mipro Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mipro Pharmaceuticals Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Niraj Kumar ceased to be Director on 31 Jan 2016.
Frequently asked questions
Mipro Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 11 December 2010 (16+ years old) and is registered under CIN U24232DL2010PTC211320.
Mipro Pharmaceuticals has 2 current directors:
- Rajeev Ranjan - Director
- Dineshchandra Prasad Gupta - Director
The latest financial statements of Mipro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mipro Pharmaceuticals is 10AAGCM9335B1ZX, registered in Bihar.
The CIN (Corporate Identification Number) of Mipro Pharmaceuticals is U24232DL2010PTC211320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mipro Pharmaceuticals was incorporated on 11 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mipro Pharmaceuticals by revenue are Means Pharmaceuticals Private Limited, Yskp Pharmaceuticals Private Limited, Rolex Pharmaceuticals Limited, Narzi Pharmaceuticals Private Limited, Diar Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Niraj Kumar ceased to be Director on 31 Jan 2016. Priyanka Kumari ceased to be Director on 31 Jan 2016. Dineshchandra Prasad Gupta was appointed as Director on 04 Mar 2013. Mipro Pharmaceuticals has 4 board changes on record in total.
The registered office of Mipro Pharmaceuticals is at E – 264 Ff Amar Colony, New Delhi, Delhi, India – 110024.
Mipro Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Mipro Pharmaceuticals is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
